Berkshire Hathaway Returns to Airlines with 26 Billion Delta Stake PreWedding Financial Conversations When a Partners Money Habits Raise Red Flags Trumps Very Disloyal Jab Texas Senator John Cornyn Faces Political Battle Amid 109 Million Ad Spending POSaBIT Schedules First Quarter 2026 Earnings Conference Call Kashkari Warns Middle East Energy Risks May Prolong Feds Cautious Stance AutoZone Stock Suffers Worst Day in Four Years Despite Earnings Beat ALDX Q1 2026 Earnings Narrowed Loss Beats Expectations as Pipeline Progress Takes Center Stage NOA Q1 2026 Earnings EPS Misses Estimates as Stock Declines 332 Aktis Oncology AKTS Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline Lufax Holding Q3 2024 Earnings Staggering EPS Miss Sends Shares Lower Exact Sciences Q4 2025 Earnings Significant EPS Miss Highlights Ongoing Investment Challenges Futu Holdings FUTU Q4 2025 Earnings Strong EPS Beat Overshadowed by Steep Stock Decline Planet Green Holdings Corp PLAG Edges Higher as Stock Tests Key Resistance at 169 Neonode Inc NEON Declines 296 as Stock Tests Key Support at 156 WW Grainger GWW Edges Higher Testing Key Resistance Zone Northrop Grumman NOC Holds Steady Near Support Amid Sector Rotation Charlton Aria Acquisition Rights CHARR Plunge on Heavy Selling Rights May Approach Expiration MVIS Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Absent TUYA Q1 2026 Earnings Slight EPS Miss Amid Steady Performance VNDA Q1 2026 Earnings EPS Miss Drives Small Decline Amid Revenue Uncertainty Edesa Biotech Inc EDSA Q1 2026 Earnings Wider Than Expected Loss as Clinical Pipeline Progresses OESX Q1 2026 Earnings Robust EPS Surprise Highlights Operational Efficiency Gains Shameful UK Welfare Spending on Benefits Over Jobs for Young People Says Alan Milburn Calls for System Reform ARGX Q1 2026 Earnings EPS Slightly Exceeds Estimates Amid Flat Stock Reaction United Maritime Corporation USEA Surges 424 Testing Key Resistance After Support Bounce Centres Ebola Travel Advisory May Impact Aviation and Pharma Sentiment Piper Sandler Raises Price Target on Charles Schwab to 105 Citing Revenue Upside from Net Interest Margin Improvement Morgan Stanleys 150Year Study Challenges Bonds as Portfolio Shock Absorbers Amid Persistent Inflation Roundhill Memory ETF Surges to Record 98 Billion as AIDriven Demand Fuels Chip Bottleneck Consumer Faces 2700 Annual Interest on 13000 Credit Card Debt Despite 19000 Savings Japans Megabanks Hit Record Profits but Headwinds May Dampen Future Growth Potential Tariff Reductions on the Horizon US Trade Representative Signals